Septic thrombophlebitis with persistent methicillin-resistant Staphylococcus aureus bacteremia and de novo resistance to vancomycin and daptomycin
Author(s) -
Yael Koton,
Zafrir Or,
Naiel Bisharat
Publication year - 2017
Publication title -
infectious disease reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.487
H-Index - 17
ISSN - 2036-7449
DOI - 10.4081/idr.2017.7008
Subject(s) - daptomycin , medicine , bacteremia , vancomycin , methicillin resistant staphylococcus aureus , staphylococcus aureus , surgery , antibiotics , microbiology and biotechnology , bacteria , biology , genetics
Persistent methicillin-resistant Staphylococcus aureus (MRSA) bacteremia is associated with significant risk of mortality, especially when it occurs while on appropriate antimicrobial therapy. We herein describe an unusual case of a patient with prosthetic aortic tissue valve, who suffered from central venous catheter related MRSA bacteremia with septic thrombus formation in the superior vena cava. MRSA bacteremia persisted despite removal of the catheter and appropriate antimicrobial therapy including vancomycin, rifampin, and daptomycin. Subsequently, the MRSA strain exhibited de novo resistance to vancomycin, rifampin and daptomycin. Eventually, salvage combination therapy with high dose daptomycin and trimethoprim-sulfamethoxazole was successful and achieved clearance of MRSA bacteremia. The case illustrates the growing complexity of treating MRSA infections
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom